101 related articles for article (PubMed ID: 2479583)
1. Binding protein, radioreceptor and biological activities of recombinant methionyl insulin-like growth factor-I variants.
Hodgkinson SC; Napier JR; Davis SR; Patel B; Gluckman PD
Mol Cell Endocrinol; 1989 Sep; 66(1):37-44. PubMed ID: 2479583
[TBL] [Abstract][Full Text] [Related]
2. Probing the disulfide folding pathway of insulin-like growth factor-I.
Milner SJ; Carver JA; Ballard FJ; Francis GL
Biotechnol Bioeng; 1999 Mar; 62(6):693-703. PubMed ID: 9951525
[TBL] [Abstract][Full Text] [Related]
3. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency.
Francis GL; Ross M; Ballard FJ; Milner SJ; Senn C; McNeil KA; Wallace JC; King R; Wells JR
J Mol Endocrinol; 1992 Jun; 8(3):213-23. PubMed ID: 1378742
[TBL] [Abstract][Full Text] [Related]
4. Development of an optimized refolding process for recombinant Ala-Glu-IGF-1.
Hejnaes KR; Bayne S; Nørskov L; Sørensen HH; Thomsen J; Schäffer L; Wollmer A; Skriver L
Protein Eng; 1992 Dec; 5(8):797-806. PubMed ID: 1287661
[TBL] [Abstract][Full Text] [Related]
5. Disulfide arrangement of human insulin-like growth factor I derived from yeast and plasma.
Axelsson K; Johansson S; Eketorp G; Zazzi H; Hemmendorf B; Gellerfors P
Eur J Biochem; 1992 Jun; 206(3):987-94. PubMed ID: 1606975
[TBL] [Abstract][Full Text] [Related]
6. Separation and characterization of modified variants of recombinant human insulin-like growth factor I derived from a fusion protein secreted from Escherichia coli.
Forsberg G; Palm G; Ekebacke A; Josephson S; Hartmanis M
Biochem J; 1990 Oct; 271(2):357-63. PubMed ID: 2173560
[TBL] [Abstract][Full Text] [Related]
7. Direct identification of disulfide bond linkages in human insulin-like growth factor I (IGF-I) by chemical synthesis.
Iwai M; Kobayashi M; Tamura K; Ishii Y; Yamada H; Niwa M
J Biochem; 1989 Dec; 106(6):949-51. PubMed ID: 2628430
[TBL] [Abstract][Full Text] [Related]
8. Direct identification of a novel disulfide bond linkage system of new isolated isomer (isomer V) in recombinantly produced h-IGF-I.
Iwai M; Yokoyama H; Yamada H; Niwa M; Kobayashi M
Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1304-9. PubMed ID: 10993229
[TBL] [Abstract][Full Text] [Related]
9. Natural and synthetic forms of insulin-like growth factor-1 (IGF-1) and the potent derivative, destripeptide IGF-1: biological activities and receptor binding.
Ballard FJ; Francis GL; Ross M; Bagley CJ; May B; Wallace JC
Biochem Biophys Res Commun; 1987 Dec; 149(2):398-404. PubMed ID: 2962574
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of insulin-like growth factor I using N-methyl pyrrolidinone as the coupling solvent and trifluoromethane sulphonic acid cleavage from the resin.
Bagley CJ; Otteson KM; May BL; McCurdy SN; Pierce L; Ballard FJ; Wallace JC
Int J Pept Protein Res; 1990 Oct; 36(4):356-61. PubMed ID: 1964154
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
12. Transfer of insulin-like growth factor (IGF)-I from blood to intestine: comparison with IGFs that bind poorly to IGF-binding proteins.
Lord AP; Martin AA; Ballard FJ; Read LC
J Endocrinol; 1994 Jun; 141(3):505-15. PubMed ID: 7520931
[TBL] [Abstract][Full Text] [Related]
13. Structural and biological characterization of bovine insulin-like growth factor binding protein-3.
Conover CA; Ronk M; Lombana F; Powell DR
Endocrinology; 1990 Dec; 127(6):2795-803. PubMed ID: 1701128
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II.
Francis GL; Aplin SE; Milner SJ; McNeil KA; Ballard FJ; Wallace JC
Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):713-9. PubMed ID: 7688957
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel binding protein for insulin-like growth factors in adult rat serum.
Shimonaka M; Schroeder R; Shimasaki S; Ling N
Biochem Biophys Res Commun; 1989 Nov; 165(1):189-95. PubMed ID: 2480123
[TBL] [Abstract][Full Text] [Related]
16. The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding.
Szabo L; Mottershead DG; Ballard FJ; Wallace JC
Biochem Biophys Res Commun; 1988 Feb; 151(1):207-14. PubMed ID: 2450535
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties.
Milner SJ; Francis GL; Wallace JC; Magee BA; Ballard FJ
Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):865-71. PubMed ID: 8948444
[TBL] [Abstract][Full Text] [Related]
18. IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys.
Tomas FM; Walton PE; Dunshea FR; Ballard FJ
J Endocrinol; 1997 Nov; 155(2):377-86. PubMed ID: 9415072
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor (IGF)-I and IGF-II binding to an IGF binding protein. An investigation using chemical modification of tyrosine residues as a structural probe for the sites of interaction.
Moss JA; Francis GL; Ross M; Wallace JC; Ballard FJ
J Biol Chem; 1991 Jan; 266(2):909-14. PubMed ID: 1702441
[TBL] [Abstract][Full Text] [Related]
20. Purified rat acid-labile subunit and recombinant human insulin-like growth factor (IGF)-binding protein-3 can form a 150-kilodalton binary complex in vitro in the absence of IGFs.
Lee CY; Rechler MM
Endocrinology; 1995 Nov; 136(11):4982-9. PubMed ID: 7588232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
